JP2015517552A5 - - Google Patents

Download PDF

Info

Publication number
JP2015517552A5
JP2015517552A5 JP2015513164A JP2015513164A JP2015517552A5 JP 2015517552 A5 JP2015517552 A5 JP 2015517552A5 JP 2015513164 A JP2015513164 A JP 2015513164A JP 2015513164 A JP2015513164 A JP 2015513164A JP 2015517552 A5 JP2015517552 A5 JP 2015517552A5
Authority
JP
Japan
Prior art keywords
composition
benzodiazepine
pharmaceutically acceptable
hygroscopic excipient
dextran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015513164A
Other languages
English (en)
Japanese (ja)
Other versions
JP6313286B2 (ja
JP2015517552A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/060543 external-priority patent/WO2013174883A1/en
Publication of JP2015517552A publication Critical patent/JP2015517552A/ja
Publication of JP2015517552A5 publication Critical patent/JP2015517552A5/ja
Application granted granted Critical
Publication of JP6313286B2 publication Critical patent/JP6313286B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015513164A 2012-05-22 2013-05-22 短時間作用型ベンゾジアゼピンを含む組成物 Active JP6313286B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12168968 2012-05-22
EP12168968.1 2012-05-22
PCT/EP2013/060543 WO2013174883A1 (en) 2012-05-22 2013-05-22 Compositions comprising short-acting benzodiazepines

Publications (3)

Publication Number Publication Date
JP2015517552A JP2015517552A (ja) 2015-06-22
JP2015517552A5 true JP2015517552A5 (enExample) 2016-05-12
JP6313286B2 JP6313286B2 (ja) 2018-04-18

Family

ID=48669863

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015513164A Active JP6313286B2 (ja) 2012-05-22 2013-05-22 短時間作用型ベンゾジアゼピンを含む組成物

Country Status (41)

Country Link
US (2) US20150148338A1 (enExample)
EP (1) EP2852389B1 (enExample)
JP (1) JP6313286B2 (enExample)
KR (1) KR102116737B1 (enExample)
CN (2) CN104968348B (enExample)
AP (1) AP2014008084A0 (enExample)
AR (1) AR092008A1 (enExample)
AU (1) AU2013265295B2 (enExample)
BR (1) BR112014029108B1 (enExample)
CA (1) CA2874247C (enExample)
CL (1) CL2014003171A1 (enExample)
CO (1) CO7151503A2 (enExample)
DK (1) DK2852389T3 (enExample)
EA (1) EA032119B1 (enExample)
EC (1) ECSP14032553A (enExample)
ES (1) ES2651389T3 (enExample)
FR (1) FR21C1043I2 (enExample)
GE (2) GEAP201813666A (enExample)
HR (1) HRP20171872T1 (enExample)
HU (2) HUE037734T2 (enExample)
IL (1) IL235789B (enExample)
LT (2) LT2852389T (enExample)
LU (1) LUC00230I2 (enExample)
MA (1) MA37581B1 (enExample)
MX (1) MX368854B (enExample)
MY (1) MY185117A (enExample)
NL (1) NL301130I2 (enExample)
NO (2) NO2852389T3 (enExample)
NZ (1) NZ702063A (enExample)
PE (1) PE20150683A1 (enExample)
PH (1) PH12014502608B1 (enExample)
PL (1) PL2852389T4 (enExample)
PT (1) PT2852389T (enExample)
RS (1) RS56660B1 (enExample)
SG (1) SG11201407710VA (enExample)
SI (1) SI2852389T1 (enExample)
TN (1) TN2014000479A1 (enExample)
TW (1) TWI590826B (enExample)
UA (1) UA115063C2 (enExample)
WO (1) WO2013174883A1 (enExample)
ZA (1) ZA201408412B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602007009128D1 (de) 2006-07-10 2010-10-21 Paion Uk Ltd Benzodiazepinsalze mit kurzzeitwirkung und polymorphe formen davon
EP2305647A1 (en) 2009-09-18 2011-04-06 PAION UK Limited Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
WO2015076340A1 (ja) * 2013-11-21 2015-05-28 小野薬品工業株式会社 全身麻酔および/または鎮静のための注射用組成物
JP6767881B2 (ja) 2014-02-10 2020-10-14 バイオルミック リミテッド 光合成生物の特徴の改善、及びそれに関する制御
AU2015230049B2 (en) 2014-03-14 2018-07-26 Biolumic Limited Method to improve crop yield and/or quality
EP3162804B1 (en) 2014-07-23 2019-10-09 Jiangsu Nhwaluokang Pharmaceutical Research and Development Co., Ltd. New benzodiazepine derivative and use thereof
MX387212B (es) 2014-09-17 2025-03-18 Biolumic Ltd Métodos para tratamiento de semillas y productos resultantes.
CN105726495B (zh) * 2014-12-12 2019-03-29 宜昌人福药业有限责任公司 一种注射用短效苯并二氮杂卓盐药物组合物及其制备方法
CN107198691A (zh) * 2016-03-17 2017-09-26 江苏恒瑞医药股份有限公司 一种瑞马唑仑的药物组合物
MX2018012498A (es) 2016-04-14 2019-07-01 Paion Uk Ltd Benzodiazepinas inhaladas y nasales oralmente.
CN108289897B (zh) * 2016-05-20 2020-07-28 江苏恒瑞医药股份有限公司 一种瑞马唑仑的药物组合物
WO2018037281A1 (en) 2016-08-22 2018-03-01 Biolumic Limited System, device and methods of seed treatment
CN108503644B (zh) 2016-12-09 2019-06-14 成都倍特药业有限公司 一种苯并二氮杂*衍生物的氢溴酸盐及其制备方法和用途
WO2019002946A1 (en) 2017-06-29 2019-01-03 Biolumic Limited METHOD OF ENHANCING YIELD AND / OR CULTURE QUALITY
EP3714884A1 (en) 2019-03-27 2020-09-30 Paion UK Limited Medical uses for benzodiazepines with a particular eeg pattern
CN112209932B (zh) * 2019-07-12 2023-03-24 成都倍特药业股份有限公司 一种化合物氢溴酸盐的新固体形态及其制备方法和用途
ES2803099B2 (es) * 2019-07-22 2021-11-08 Moehs Iberica Sl Procedimiento de obtención de besilato de remimazolam amorfo
CN114478535B (zh) * 2020-10-23 2024-02-09 成都苑东生物制药股份有限公司 一种苯磺酸瑞马唑仑ii晶型的制备方法
CN112462015B (zh) * 2020-11-18 2022-07-12 海南倍特药业有限公司 一种氢溴酸瑞马唑仑细菌内毒素的检测方法
CN114624351B (zh) * 2020-12-14 2024-04-09 宜昌人福药业有限责任公司 苯磺酸瑞马唑仑原料药中(r)-(-)-1-氨基-2-丙醇残留的分析方法
KR20250156085A (ko) * 2022-12-16 2025-10-31 에르테에스 로만 테라피-시스테메 아게 레미마졸람을 포함하는 구강 점막 전달 시스템
CN119101054A (zh) * 2023-06-09 2024-12-10 成都麻沸散医药科技有限公司 一种氮杂䓬类化合物及其组合物和应用
WO2025052259A1 (en) 2023-09-05 2025-03-13 Reena Patel Ready to use compositions of remimazolam

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3520877A (en) * 1967-10-02 1970-07-21 Hoffmann La Roche 3-carbonyl amino acetic acid ethyl ester substituted benzodiazepines
CA2143246C (en) 1994-03-16 2000-08-22 Thierry Godel Imidazodiazepines
AU4296196A (en) 1995-01-06 1996-07-24 F. Hoffmann-La Roche Ag Hydroxymethylimidazodiazepines and their esters
AU4382896A (en) 1995-02-02 1996-08-21 F. Hoffmann-La Roche Ag Acetylimidazobenzodiazepines
JPH0971533A (ja) * 1995-06-30 1997-03-18 Takeda Chem Ind Ltd 凍結乾燥製剤
GB9911152D0 (en) * 1999-05-14 1999-07-14 Glaxo Group Ltd Short-acting benzodiazepines
US7160880B1 (en) * 1999-05-14 2007-01-09 Cenes Limited Short-acting benzodiazepines
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
EP1161949A1 (en) * 2000-06-09 2001-12-12 Warner-Lambert Company Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease
EA013433B1 (ru) * 2005-02-15 2010-04-30 Элан Фарма Интернэшнл Лтд. Аэрозольные и впрыскиваемые рецептуры лекарственных препаратов бензодиазепина, состоящего из наночастиц
DE602007009128D1 (de) * 2006-07-10 2010-10-21 Paion Uk Ltd Benzodiazepinsalze mit kurzzeitwirkung und polymorphe formen davon
GB0613692D0 (en) * 2006-07-10 2006-08-16 Cenes Ltd Benzodiazepine salts
GB0613693D0 (en) * 2006-07-10 2006-08-16 Cenes Ltd Benzodiazepine salts (3)
CN101352422B (zh) * 2008-09-17 2011-04-20 厦门朝阳生物工程有限公司 河豚毒素冻干粉针制剂及其制备方法
KR20120097508A (ko) * 2009-11-05 2012-09-04 글락소스미스클라인 엘엘씨 벤조디아제핀 브로모도메인 억제제
EP2450039A1 (en) * 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
CN102964349A (zh) 2011-08-31 2013-03-13 江苏恒瑞医药股份有限公司 苯并二氮杂*衍生物的托西酸盐及其多晶型、它们的制备方法和用途

Similar Documents

Publication Publication Date Title
JP2015517552A5 (enExample)
HRP20171872T1 (hr) Pripravci koji sadrže benzodiazepine kratkog djelovanja
SI2683708T1 (en) Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
WO2016184576A3 (en) Dry powder composition comprising long-chain rna
JP2010502751A5 (enExample)
JP2018537437A5 (enExample)
TWI455939B (zh) cMET抑制劑
JP2014514346A5 (enExample)
JP2013511557A5 (enExample)
JP2012517969A5 (enExample)
JP2016515561A5 (enExample)
JP2017526726A5 (enExample)
JP2013534248A5 (enExample)
EA201170527A1 (ru) Фармацевтические композиции, включающие соединения бороновой кислоты
JP2013532729A5 (enExample)
TWI609869B (zh) 二氫吡咯并[1,2-c]咪唑基皮質醛酮素合成酶或芳族酶抑制劑之新穎型式及鹽
IN2012DE00337A (enExample)
JP2015512432A5 (enExample)
JP2016520075A5 (enExample)
WO2010007316A3 (fr) NOUVEAUX DERIVES TRIAZOLO(4,3-a)PYRIDINE,LEUR PROCEDE DE PREPARATION,LEUR APPLICATION A TITRE DE MEDICAMENTS,COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE MET
JP2013518036A5 (enExample)
RU2016123379A (ru) Тетрагидротриазолопиримидиновые соединения в качестве ингибиторов нейтрофильной эластазы человека
JP2015509075A5 (enExample)
JP2016540803A5 (enExample)
JP2015511957A5 (enExample)